Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesStage III Colorectal Cancer: Molecular Disparity Between Primary Cancers and Lymph Node Metastases
Annals of Surgical Oncology, 11/09/09
Messick CA et al. – Molecular characterization, notably the CpG island methylator phenotype, varies between primary tumors and corresponding lymphatic metastases. Although the mechanism for this is unknown, this finding suggests that molecular typing of LNs as well as primary tumors should be considered for molecular–based adjuvant therapy decisions.
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09
Sponsor
Article Search
Sponsor